Why the study?
Heart transplantation has been suggested for refractory electrical storm, but data regarding the outcomes of these patients remain scarce.
Does urgent heart transplantation during index hospitalization reduce in-hospital all-cause mortality compared to medical and interventional management without immediate transplantation in patients listed for urgent heart transplantation due to refractory electrical storm?
Does urgent heart transplantation during index hospitalization reduce in-hospital all-cause mortality compared to medical and interventional management without immediate transplantation in patients listed for urgent heart transplantation due to refractory electrical storm?
In patients listed for urgent heart transplantation due to refractory electrical storm, in-hospital mortality is high (~30-35%) and does not significantly differ overall between those who undergo immediate transplant and those who do not, although patients presenting with cardiogenic shock derive a significant survival benefit from urgent transplantation.
Answers are grounded in this paper and cite their sources.
High mortality persists in refractory electrical storm regardless of transplantation; leaves open benefit of urgent listing pending prospective data.
Background: Heart transplantation (HTx) has been suggested for refractory electrical storm (ES). Data regarding the outcomes of these patients are scarce. Objective: To compare the prognosis of refractory ES patients listed for urgent HTx, with and without transplantation. Methods: Patients registered on urgent HTx waiting list for refractory ES were retrospectively included in 13 French centers between 2010-2022. The primary endpoint was in-hospital all-cause mortality. Results: Eighty-five patients were included (85.9% men; 56.0 [48.0-61.0] years old; 55.1% with dilated cardiomyopathy), among whom 45 (52.9%) ultimately underwent HTx during index hospitalization. In the overall cohort, 89.3% of patients received amiodarone, 64.3% beta-blockers, 45.9% required deep sedation, 5.9% underwent stellate ganglion block, and 41.2% received mechanical circulatory support. Catheter ablation was less frequently performed in the transplanted group (20.0% vs 57.5%, p < 0.01). No difference was found for in-hospital mortality between transplanted and non-transplanted patients (28.9% vs 35.0%, HR 0.72 [0.34-1.53], p=0.0.39). After 1-year follow-up, 14 patients (16.5%) of the non-transplanted group eventually underwent HTx, with 4 of them dying subsequently. Five patients (5.9%) were removed from HTx waiting list due to functional improvement. Conversely, 14 transplanted patients (16.5%) died. Conclusion: Refractory ES carries a high in-hospital mortality rate, affecting one-third of patients. Overall, 69.4% of patients listed for urgent HTx underwent transplantation, including 52.9% during index hospitalization and 16.5% within the year post-discharge, highlighting the need to optimize selection criteria and implement a comprehensive treatment that sometimes allows overcoming the acute phase, enabling HTx under more stable conditions.
No takes yet. Share an insight, caveat, or question.
Cherbi et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: